pdb_id,title,method,resolution,release_date,revision_date
1HSB,DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE,X-RAY DIFFRACTION,1.9,1993-10-31T00:00:00+0000,2024-10-30T00:00:00+0000
1SYV,HLA-B*4405 complexed to the dominant self ligand EEFGRAYGF,X-RAY DIFFRACTION,1.7,2004-10-19T00:00:00+0000,2024-11-13T00:00:00+0000
1YDP,1.9A crystal structure of HLA-G,X-RAY DIFFRACTION,1.9,2005-03-08T00:00:00+0000,2024-10-23T00:00:00+0000
1ZVS,Crystal structure of the first class MHC mamu and Tat-Tl8 complex,X-RAY DIFFRACTION,2.8,2006-06-13T00:00:00+0000,2024-11-20T00:00:00+0000
3HG1,Germline-governed recognition of a cancer epitope by an immunodominant human T cell receptor,X-RAY DIFFRACTION,3.0,2009-07-28T00:00:00+0000,2024-11-27T00:00:00+0000
3KPN,Crystal Structure of HLA B*4403 in complex with EEYLQAFTY a self peptide from the ABCD3 protein,X-RAY DIFFRACTION,2.0,2009-12-22T00:00:00+0000,2024-10-16T00:00:00+0000
3KPO,"Crystal Structure of HLA B*4403 in complex with EEYLKAWTF, a mimotope",X-RAY DIFFRACTION,2.3,2009-12-22T00:00:00+0000,2024-10-30T00:00:00+0000
3KYN,Crystal structure of HLA-G presenting KGPPAALTL peptide,X-RAY DIFFRACTION,2.4,2010-02-23T00:00:00+0000,2024-11-20T00:00:00+0000
3KYO,Crystal structure of HLA-G presenting KLPAQFYIL peptide,X-RAY DIFFRACTION,1.7,2010-02-23T00:00:00+0000,2024-10-30T00:00:00+0000
3O4L,Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus,X-RAY DIFFRACTION,2.54,2011-01-12T00:00:00+0000,2024-11-06T00:00:00+0000
3OX8,Crystal Structure of HLA A*02:03 Bound to HBV Core 18-27,X-RAY DIFFRACTION,2.16,2011-05-04T00:00:00+0000,2024-10-30T00:00:00+0000
3OXR,Crystal Structure of HLA A*02:06 Bound to HBV Core 18-27,X-RAY DIFFRACTION,1.7,2011-05-04T00:00:00+0000,2024-11-20T00:00:00+0000
3OXS,Crystal Structure of HLA A*02:07 Bound to HBV Core 18-27,X-RAY DIFFRACTION,1.75,2011-05-04T00:00:00+0000,2024-10-09T00:00:00+0000
3TO2,Structure of HLA-A*0201 complexed with peptide Md3-C9 derived from a clustering region of restricted cytotoxic T lymphocyte epitope from SARS-CoV M protein,X-RAY DIFFRACTION,2.6,2012-08-29T00:00:00+0000,2024-10-30T00:00:00+0000
3VFM,"crystal structure of HLA B*3508 LPEP155A, HLA mutant Ala155",X-RAY DIFFRACTION,1.9,2012-03-07T00:00:00+0000,2024-10-16T00:00:00+0000
3VFN,"crystal structure of HLA B*3508LPEP151A, HLA mutant Ala151",X-RAY DIFFRACTION,1.5,2012-03-07T00:00:00+0000,2024-11-27T00:00:00+0000
3VFO,"crystal structure of HLA B*3508 LPEP157A, HLA mutant Ala157",X-RAY DIFFRACTION,1.7,2012-03-07T00:00:00+0000,2024-10-30T00:00:00+0000
3VFP,"crystal structure of HLA B*3508 LPEP158G, HLA mutant Gly158",X-RAY DIFFRACTION,1.85,2012-03-07T00:00:00+0000,2024-11-20T00:00:00+0000
3VFR,"crystal structure of HLA B*3508LPEP-P4Ala, peptide mutant P4-ala",X-RAY DIFFRACTION,1.85,2012-03-07T00:00:00+0000,2024-10-30T00:00:00+0000
3VFS,"crystal structure of HLA B*3508LPEP-P5Ala , peptide mutant P5-ala",X-RAY DIFFRACTION,1.85,2012-02-22T00:00:00+0000,2024-11-20T00:00:00+0000
3VFT,"crystal structure of HLA B*3508LPEP-P6Ala, peptide mutant P6-ala",X-RAY DIFFRACTION,1.947,2012-02-22T00:00:00+0000,2024-10-30T00:00:00+0000
3VFU,"crystal structure of HLA B*3508 LPEP-P7Ala, peptide mutant P7-ala",X-RAY DIFFRACTION,1.65,2012-02-22T00:00:00+0000,2024-11-06T00:00:00+0000
3VFV,"crystal structure of HLA B*3508 LPEP-P9Ala, peptide mutant P9-ala",X-RAY DIFFRACTION,1.55,2012-02-22T00:00:00+0000,2024-10-16T00:00:00+0000
3VFW,"crystal structure of HLA B*3508 LPEP-P10Ala, peptide mutant P10-ala",X-RAY DIFFRACTION,2.3,2012-02-22T00:00:00+0000,2024-10-16T00:00:00+0000
4GKN,A2-MHC Complex carrying FATGIGIITV,X-RAY DIFFRACTION,2.753,2012-09-12T00:00:00+0000,2024-11-20T00:00:00+0000
4HX1,Structure of HLA-A68 complexed with a tumor antigen derived peptide,X-RAY DIFFRACTION,1.802,2013-10-02T00:00:00+0000,2024-11-13T00:00:00+0000
4JRX,Crystal Structure of CA5 TCR-HLA B*3505-LPEP complex,X-RAY DIFFRACTION,2.3,2013-04-10T00:00:00+0000,2024-10-16T00:00:00+0000
4JRY,Crystal Structure of SB47 TCR-HLA B*3505-LPEP complex,X-RAY DIFFRACTION,2.8,2013-04-10T00:00:00+0000,2024-10-30T00:00:00+0000
4PRA,Crystal structure of a HLA-B*35:01-HPVG-Q5,X-RAY DIFFRACTION,1.85,2014-04-16T00:00:00+0000,2024-10-16T00:00:00+0000
4PRB,Crystal structure of a HLA-B*35:08-HPVG-A4,X-RAY DIFFRACTION,1.75,2014-04-16T00:00:00+0000,2024-11-27T00:00:00+0000
4PRD,Crystal structure of a HLA-B*35:08-HPVG-D5,X-RAY DIFFRACTION,1.75,2014-04-16T00:00:00+0000,2024-10-16T00:00:00+0000
4PRE,Crystal structure of a HLA-B*35:08-HPVG-Q5,X-RAY DIFFRACTION,1.65,2014-04-16T00:00:00+0000,2024-11-20T00:00:00+0000
4PRH,Crystal structure of TK3 TCR-HLA-B*35:08-HPVG-D5 complex,X-RAY DIFFRACTION,2.5,2014-04-30T00:00:00+0000,2024-10-30T00:00:00+0000
4PRI,Crystal structure of TK3 TCR-HLA-B*35:08-HPVG complex,X-RAY DIFFRACTION,2.4,2014-04-16T00:00:00+0000,2024-11-20T00:00:00+0000
4PRP,Crystal structure of TK3 TCR-HLA-B*35:01-HPVG-Q5 complex,X-RAY DIFFRACTION,2.5,2014-04-16T00:00:00+0000,2024-11-27T00:00:00+0000
5DEG,Crystal structure of B*27:06 bound to the pVIPR peptide,X-RAY DIFFRACTION,1.83,2015-11-18T00:00:00+0000,2024-10-23T00:00:00+0000
5NQ1,"Porcine (Sus scrofa) Major Histocompatibility Complex, class I, with human beta2 micro globulin, presenting DFEREGYSL",X-RAY DIFFRACTION,2.14,2018-04-25T00:00:00+0000,2024-11-13T00:00:00+0000
5NQ3,"'Porcine (Sus scrofa) Major Histocompatibility Complex, class I, with human beta2 micro globulin, presenting EFEDLTFLA",X-RAY DIFFRACTION,1.57,2018-04-25T00:00:00+0000,2024-10-16T00:00:00+0000
5VVP,HLA-B*57:03 presenting LSSPVTKSW,X-RAY DIFFRACTION,2.0,2018-10-03T00:00:00+0000,2024-11-06T00:00:00+0000
5VWD,HLA-B*57:03 presenting LTVQVARVW,X-RAY DIFFRACTION,1.8,2018-10-03T00:00:00+0000,2024-11-20T00:00:00+0000
5VWF,HLA-B*58:03 presenting LTVQVARVY,X-RAY DIFFRACTION,1.8,2018-10-03T00:00:00+0000,2024-11-20T00:00:00+0000
6BXQ,Crystal Structure of HLA-B*57:01 with an HIV peptide RKV,X-RAY DIFFRACTION,1.58,2018-02-28T00:00:00+0000,2024-10-23T00:00:00+0000
6GGM,HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P2-Phe.,X-RAY DIFFRACTION,2.734,2018-08-08T00:00:00+0000,2024-10-16T00:00:00+0000
6GH1,HLA-E*01:03 in complex with Mtb44,X-RAY DIFFRACTION,2.1,2018-08-08T00:00:00+0000,2024-10-23T00:00:00+0000
6GH4,HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P2-Gln.,X-RAY DIFFRACTION,2.16,2018-08-08T00:00:00+0000,2024-10-23T00:00:00+0000
6GL1,"HLA-E*01:03 in complex with the HIV epitope, RL9HIV",X-RAY DIFFRACTION,2.623,2018-08-08T00:00:00+0000,2024-10-16T00:00:00+0000
6ID4,Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01,X-RAY DIFFRACTION,2.4,2019-02-06T00:00:00+0000,2024-10-23T00:00:00+0000
6IEX,Crystal structure of HLA-B*4001 in complex with SARS-CoV derived peptide N216-225 GETALALLLL,X-RAY DIFFRACTION,2.314,2019-09-18T00:00:00+0000,2024-10-16T00:00:00+0000
6J2E,Crystal structure of bat (Pteropus Alecto) MHC class I Ptal-N*01:01 in complex with Ebola virus-derived peptide EBOV-NP1,X-RAY DIFFRACTION,2.1,2019-09-18T00:00:00+0000,2024-11-13T00:00:00+0000
6K7T,Crystal structure of bat (Pteropus Alecto) MHC class I Ptal-N*01:01 in complex with Hendra virus-derived peptide HeV1--human beta-2 microglobulin,X-RAY DIFFRACTION,1.6,2019-11-06T00:00:00+0000,2024-11-13T00:00:00+0000
6MTL,Crystal Structure of HLA-B*44:05 in complex with NP338 influenza peptide,X-RAY DIFFRACTION,1.35,2019-02-13T00:00:00+0000,2024-10-16T00:00:00+0000
6O4Y,Structure of HLA-A2:01 with peptide MM91,X-RAY DIFFRACTION,1.58,2020-01-15T00:00:00+0000,2024-11-13T00:00:00+0000
6O4Z,Structure of HLA-A2:01 with peptide MM92,X-RAY DIFFRACTION,1.5,2020-01-15T00:00:00+0000,2024-10-09T00:00:00+0000
6O51,Structure of HLA-A2:01 with peptide MM90,X-RAY DIFFRACTION,1.55,2020-01-15T00:00:00+0000,2024-10-23T00:00:00+0000
6O53,Structure of HLA-A2:01 with peptide MM96,X-RAY DIFFRACTION,1.4,2020-01-15T00:00:00+0000,2024-10-23T00:00:00+0000
6P2S,Structure of a nested set of N-terminally extended MHC I-peptides provide novel insights into antigen processing and presentation,X-RAY DIFFRACTION,1.65,2019-10-16T00:00:00+0000,2024-10-16T00:00:00+0000
6P64,Alpha-beta TCR Binding to Neoantigen KQWLVWLFL Presented by HLA-A206,X-RAY DIFFRACTION,3.05,2020-06-03T00:00:00+0000,2024-11-20T00:00:00+0000
6TDO,Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one GM dipeptide in the A pocket.,X-RAY DIFFRACTION,1.65,2020-03-25T00:00:00+0000,2024-10-09T00:00:00+0000
6TDP,Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one GL dipeptide in the A pocket.,X-RAY DIFFRACTION,1.4,2020-03-25T00:00:00+0000,2024-11-06T00:00:00+0000
6TDQ,Crystal structure of the disulfide engineered HLA-A0201 molecule in complex with one GM dipeptide in the A pocket and one GM dipeptide in the F pocket.,X-RAY DIFFRACTION,1.6,2020-03-25T00:00:00+0000,2024-10-16T00:00:00+0000
6TDR,Crystal structure of the disulfide engineered HLA-A0201 molecule devoid of peptide (annealed),X-RAY DIFFRACTION,1.75,2020-03-25T00:00:00+0000,2024-10-23T00:00:00+0000
6TDS,Crystal structure of the disulfide engineered HLA-A0201 molecule without peptide bound after NaCl wash,X-RAY DIFFRACTION,1.7,2020-03-25T00:00:00+0000,2024-11-20T00:00:00+0000
6TMO,"Structure determination of an enhanced affinity TCR, a24b17, in complex with HLA-A*02:01 presenting a MART-1 peptide, EAAGIGILTV",X-RAY DIFFRACTION,2.1,2020-10-07T00:00:00+0000,2024-11-13T00:00:00+0000
6TRN,Crystal structure of HLA A2*01-AVYDGREHTV,X-RAY DIFFRACTION,1.35,2020-06-24T00:00:00+0000,2024-11-06T00:00:00+0000
6TRO,Crystal structure of the T-cell receptor GVY01 bound to HLA A2*01-GVYDGREHTV,X-RAY DIFFRACTION,3.0,2020-06-24T00:00:00+0000,2024-10-23T00:00:00+0000
6UJO,HHAT L75F Neoantigen Peptide KQWLVWLFL Presented by HLA-A206,X-RAY DIFFRACTION,2.25,2020-08-19T00:00:00+0000,2024-11-06T00:00:00+0000
6UJQ,HHAT Wild Type Peptide KQWLVWLLL Presented by HLA-A206,X-RAY DIFFRACTION,2.55,2020-08-19T00:00:00+0000,2024-10-23T00:00:00+0000
6UK2,Complex of T cell Receptor with HHAT Wild Type Peptide KQWLVWLLL Presented by HLA-A206,X-RAY DIFFRACTION,3.13880812156,2020-08-19T00:00:00+0000,2024-10-30T00:00:00+0000
6UK4,Complex of T cell Receptor with HHAT Neoantigen Peptide KQWLVWLFL Presented by HLA-A206,X-RAY DIFFRACTION,2.7,2020-08-19T00:00:00+0000,2024-11-06T00:00:00+0000
6UZM,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,1.798,2020-11-18T00:00:00+0000,2024-10-23T00:00:00+0000
6UZN,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.22,2020-11-18T00:00:00+0000,2024-10-30T00:00:00+0000
6UZO,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.349,2020-11-18T00:00:00+0000,2024-11-20T00:00:00+0000
6UZP,HLA-B*15:01 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.08,2020-11-18T00:00:00+0000,2024-11-20T00:00:00+0000
6UZQ,HLA-B*15:01 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.395,2020-11-18T00:00:00+0000,2024-11-13T00:00:00+0000
6UZS,HLA-B*15:01 complexed with a synthetic peptide,X-RAY DIFFRACTION,1.9,2020-11-18T00:00:00+0000,2024-11-06T00:00:00+0000
6V2O,HLA-B*57:01 presenting the peptide ASLNLPAVSW,X-RAY DIFFRACTION,1.27,2020-05-20T00:00:00+0000,2024-10-30T00:00:00+0000
6VB0,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,1.9,2020-11-25T00:00:00+0000,2024-11-13T00:00:00+0000
6VB1,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,1.75,2020-11-25T00:00:00+0000,2024-10-23T00:00:00+0000
6VB2,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,1.41,2020-11-25T00:00:00+0000,2024-10-30T00:00:00+0000
6VB3,HLA-B*15:01 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.0,2020-11-25T00:00:00+0000,2024-11-20T00:00:00+0000
6VB4,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.334,2020-11-25T00:00:00+0000,2024-10-30T00:00:00+0000
6VB5,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.15,2020-11-25T00:00:00+0000,2024-11-20T00:00:00+0000
6VB6,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.15,2020-11-25T00:00:00+0000,2024-11-06T00:00:00+0000
6VB7,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.1,2020-11-25T00:00:00+0000,2024-11-20T00:00:00+0000
6VIU,HLA-B*15:02 complexed with a synthetic peptide,X-RAY DIFFRACTION,2.334,2020-11-25T00:00:00+0000,2024-10-30T00:00:00+0000
6VPZ,HLA-B*27:05 presenting an HIV-1 11mer peptide,X-RAY DIFFRACTION,2.1,2021-02-10T00:00:00+0000,2024-10-23T00:00:00+0000
6VQ2,HLA-B*27:05 presenting an HIV-1 14mer peptide,X-RAY DIFFRACTION,2.25,2021-02-10T00:00:00+0000,2024-10-16T00:00:00+0000
6VQD,HLA-B*27:05 presenting an HIV-1 8mer peptide,X-RAY DIFFRACTION,1.88,2021-02-10T00:00:00+0000,2024-10-23T00:00:00+0000
6VQE,HLA-B*27:05 presenting an HIV-1 13mer peptide,X-RAY DIFFRACTION,1.77,2021-02-10T00:00:00+0000,2024-10-30T00:00:00+0000
6VQO,T cell receptor-p53-HLA-A2 complex,X-RAY DIFFRACTION,3.0,2020-06-17T00:00:00+0000,2024-11-06T00:00:00+0000
6VQY,HLA-B*27:05 presenting an HIV-1 7mer peptide,X-RAY DIFFRACTION,2.57,2021-02-10T00:00:00+0000,2024-10-30T00:00:00+0000
6VQZ,HLA-B*27:05 presenting an HIV-1 6mer peptide,X-RAY DIFFRACTION,2.25,2021-02-10T00:00:00+0000,2024-11-13T00:00:00+0000
6VR1,"Complex of HLA-A2, a class I MHC, with a p53 peptide",X-RAY DIFFRACTION,2.37,2020-06-10T00:00:00+0000,2024-10-30T00:00:00+0000
6VR5,"Complex of HLA-A2, a class I MHC, with a p53 peptide",X-RAY DIFFRACTION,2.38,2020-06-17T00:00:00+0000,2024-10-23T00:00:00+0000
6VRM,T cell receptor-p53-HLA-A2 complex,X-RAY DIFFRACTION,2.61,2020-06-17T00:00:00+0000,2024-11-20T00:00:00+0000
6VRN,T cell receptor-p53-HLA-A2 complex,X-RAY DIFFRACTION,2.46,2020-06-17T00:00:00+0000,2024-11-20T00:00:00+0000
6W51,Structure of the antibody fragment H2 in complex with HLA-A*02:01/p53R175H,X-RAY DIFFRACTION,3.53,2021-03-17T00:00:00+0000,2024-11-20T00:00:00+0000
6XQA,"Crystal Structure of HLA A*2402 in complex with TYQWVLKNL, an 9-mer epitope from Influenza B virus",X-RAY DIFFRACTION,2.16,2021-04-14T00:00:00+0000,2024-11-06T00:00:00+0000
6Y26,Crystal structure of HLA-B2705 complexed with the nona-peptide mA,X-RAY DIFFRACTION,1.2,2020-12-23T00:00:00+0000,2024-11-20T00:00:00+0000
6Y28,Crystal structure of HLA-B2705 complexed with the nona-peptide mE,X-RAY DIFFRACTION,1.69,2020-12-23T00:00:00+0000,2024-11-20T00:00:00+0000
6Y2A,Crystal structure of HLA-B2705 complexed with the nona-peptide mQ,X-RAY DIFFRACTION,1.25,2020-12-23T00:00:00+0000,2024-10-16T00:00:00+0000
6Z9V,"Human Class I Major Histocompatibility Complex, A02 allele, presenting IIGWMWIPV",X-RAY DIFFRACTION,2.01,2021-06-30T00:00:00+0000,2024-11-13T00:00:00+0000
6Z9W,"Human Class I Major Histocompatibility Complex, A02 allele, presenting LLGWVFAQV",X-RAY DIFFRACTION,2.7,2021-06-30T00:00:00+0000,2024-10-23T00:00:00+0000
6Z9X,"Human Class I Major Histocompatibility Complex, A02 allele, presenting LLS (t-butyl)Y FGTPT",X-RAY DIFFRACTION,2.68,2021-06-30T00:00:00+0000,2024-07-10T00:00:00+0000
7BBG,CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06,X-RAY DIFFRACTION,2.64,2021-10-27T00:00:00+0000,2024-10-16T00:00:00+0000
7CIQ,Phosphorylation modification of MHC I polypeptide,X-RAY DIFFRACTION,1.59,2022-03-09T00:00:00+0000,2024-11-20T00:00:00+0000
7CIR,Peptide phosphorylation modification of MHC class I molecules,X-RAY DIFFRACTION,1.81,2022-03-09T00:00:00+0000,2024-10-23T00:00:00+0000
7CIS,Peptide modification of MHC class I molecules,X-RAY DIFFRACTION,2.1,2022-03-09T00:00:00+0000,2024-11-06T00:00:00+0000
7DUU,Crystal structure of HLA molecule with an KIR receptor,X-RAY DIFFRACTION,2.51,2022-02-02T00:00:00+0000,2024-10-16T00:00:00+0000
7DYN,Phosphorylation of MHC I peptide,X-RAY DIFFRACTION,2.0,2022-03-09T00:00:00+0000,2024-10-16T00:00:00+0000
7DZM,Crystal Structure of the cross-restricted T18A TCR and HLAB8101 bound to HIV-1 Gag TL9 peptide,X-RAY DIFFRACTION,2.25,2022-01-26T00:00:00+0000,2024-11-20T00:00:00+0000
7DZN,Crystal Structure of the cross-restricted T18A TCR and HLAB4201 bound to HIV-1 Gag TL9 peptide,X-RAY DIFFRACTION,2.63,2022-01-26T00:00:00+0000,2024-11-20T00:00:00+0000
7EDO,First insight into marsupial MHC I peptide presentation: immune features of lower mammals paralleled with bats,X-RAY DIFFRACTION,2.7,2021-08-11T00:00:00+0000,2024-10-23T00:00:00+0000
7EJL,Complex Structure of HLA-A*2402 with the Peptide from HCoV(CoV-2) spike protein,X-RAY DIFFRACTION,1.89,2022-01-26T00:00:00+0000,2024-10-23T00:00:00+0000
7EJM,Complex Structure of HLA-A*2402 with the Peptide from HCoV(CoV-229E) spike protein,X-RAY DIFFRACTION,1.71,2022-01-26T00:00:00+0000,2024-11-06T00:00:00+0000
7EJN,Complex Structure of HLA-A*2402 with the Peptide from HCoV(CoV-HKU1) spike protein,X-RAY DIFFRACTION,2.11,2022-01-26T00:00:00+0000,2024-11-20T00:00:00+0000
7EU2,Complex structure of HLA0201 with recognizing SARS-CoV-2 epitope S1,X-RAY DIFFRACTION,2.8,2021-08-25T00:00:00+0000,2024-10-16T00:00:00+0000
7F4W,Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope pep4,X-RAY DIFFRACTION,2.9,2021-08-25T00:00:00+0000,2024-10-16T00:00:00+0000
7JYU,"Crystal Structure of HLA-A*2402 in complex with IYFSPIRVTF, an 10-mer epitope from Influenza B virus",X-RAY DIFFRACTION,2.75,2021-04-14T00:00:00+0000,2024-11-20T00:00:00+0000
7JYV,"Crystal Structure of HLA A*2402 in complex with YFSPIRVTF, an 9-mer influenza epitope",X-RAY DIFFRACTION,1.51,2021-04-14T00:00:00+0000,2024-10-30T00:00:00+0000
7JYW,"Crystal Structure of HLA A*2402 in complex with TYQWIIRNW, an 9-mer influenza epitope",X-RAY DIFFRACTION,2.9,2021-04-14T00:00:00+0000,2024-11-06T00:00:00+0000
7JYX,"Crystal Structure of HLA A*2402 in complex with TYQWIIRNWET, an 11-mer epitope from Influenza",X-RAY DIFFRACTION,2.95,2021-04-14T00:00:00+0000,2024-11-06T00:00:00+0000
7K80,KIR3DL1*001 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide,X-RAY DIFFRACTION,2.4,2020-12-09T00:00:00+0000,2024-10-09T00:00:00+0000
7K81,KIR3DL1*005 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide,X-RAY DIFFRACTION,2.0,2020-12-09T00:00:00+0000,2024-10-23T00:00:00+0000
7KGO,Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N351-359,X-RAY DIFFRACTION,2.15,2021-01-20T00:00:00+0000,2024-11-20T00:00:00+0000
7KGP,Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N316-324,X-RAY DIFFRACTION,1.396,2021-01-20T00:00:00+0000,2024-11-06T00:00:00+0000
7KGQ,Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N222-230,X-RAY DIFFRACTION,1.34,2021-01-20T00:00:00+0000,2024-11-20T00:00:00+0000
7KGR,Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N159-167,X-RAY DIFFRACTION,1.55,2021-01-20T00:00:00+0000,2024-11-20T00:00:00+0000
7KGS,Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N138-146,X-RAY DIFFRACTION,1.58,2021-01-20T00:00:00+0000,2024-10-23T00:00:00+0000
7KGT,Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N226-234,X-RAY DIFFRACTION,1.9,2021-01-20T00:00:00+0000,2024-10-16T00:00:00+0000
7LG2,Human leukocyte antigen A*0201 in complex with SARS-CoV2 epitope ALWEIQQVV,X-RAY DIFFRACTION,2.4,2021-02-03T00:00:00+0000,2024-11-13T00:00:00+0000
7LG3,Human leukocyte antigen A*0201 in complex with SARS-CoV2 epitope KLWAQCVQL,X-RAY DIFFRACTION,2.3,2021-02-03T00:00:00+0000,2024-10-30T00:00:00+0000
7MJ6,HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide,X-RAY DIFFRACTION,1.95,2021-08-18T00:00:00+0000,2024-10-30T00:00:00+0000
7MJ7,HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide,X-RAY DIFFRACTION,1.6,2021-08-18T00:00:00+0000,2024-10-09T00:00:00+0000
7MJ8,HLA-A*02:01 bound to Neuroblastoma Derived IGFBPL1 peptide,X-RAY DIFFRACTION,1.79,2021-08-18T00:00:00+0000,2024-10-23T00:00:00+0000
7MJ9,HLA-A*02:01 bound to Neuroblastoma Derived mutant IGFBPL1 peptide,X-RAY DIFFRACTION,1.75,2021-08-18T00:00:00+0000,2024-10-09T00:00:00+0000
7MKB,Human leukocyte antigen A*0201 in complex with SARS-CoV-2 epitope YLQPRTFLL,X-RAY DIFFRACTION,1.9,2021-05-26T00:00:00+0000,2024-10-30T00:00:00+0000
7N6D,HLA peptide complex,X-RAY DIFFRACTION,2.3,2021-07-28T00:00:00+0000,2024-10-16T00:00:00+0000
7N6E,TCR peptide HLA-A2 complex,X-RAY DIFFRACTION,3.2,2021-07-28T00:00:00+0000,2024-11-13T00:00:00+0000
7NMD,Human Major Histocompatibility Complex A24 Allele presenting QLPRLFPLL,X-RAY DIFFRACTION,2.25,2022-09-07T00:00:00+0000,2024-10-23T00:00:00+0000
7NME,"Human MHC Class I, A24 Allele presenting QLPRLFPLL, Complex with 4C6 TCR",X-RAY DIFFRACTION,2.2,2022-09-07T00:00:00+0000,2024-11-13T00:00:00+0000
7NMF,"Human MHC Class I, A24 Allele presenting QLPRLFPLL, Complex with 4C6 TCR, monoclinic form",X-RAY DIFFRACTION,2.98,2022-09-07T00:00:00+0000,2024-10-23T00:00:00+0000
7NMG,"Human MHC Class I, A24 Allele presenting LWM, Complex with 4C6 TCR",X-RAY DIFFRACTION,2.48,2022-09-07T00:00:00+0000,2024-11-06T00:00:00+0000
7OW3,Crystal structure of HLA-A*11:01 in complex with KRAS peptide (VVVGAGGVGK),X-RAY DIFFRACTION,2.46,2022-07-20T00:00:00+0000,2024-10-16T00:00:00+0000
7OW4,Crystal structure of HLA-A*11:01 in complex with KRAS G12D peptide (VVVGADGVGK),X-RAY DIFFRACTION,1.81,2022-07-20T00:00:00+0000,2024-10-16T00:00:00+0000
7OW5,Crystal structure of a TCR in complex with HLA-A*11:01 bound to KRAS peptide (VVVGAGGVGK),X-RAY DIFFRACTION,2.58,2022-07-20T00:00:00+0000,2024-11-20T00:00:00+0000
7OW6,Crystal structure of a TCR in complex with HLA-A*11:01 bound to KRAS G12D peptide (VVVGADGVGK),X-RAY DIFFRACTION,2.64,2022-07-20T00:00:00+0000,2024-11-20T00:00:00+0000
7P3D,MHC I A02 Allele presenting YLQPRTFLL,X-RAY DIFFRACTION,1.67,2021-07-28T00:00:00+0000,2024-11-20T00:00:00+0000
7P3E,MHC I A02 Allele presenting YLQLRTFLL,X-RAY DIFFRACTION,2.0,2021-07-28T00:00:00+0000,2024-10-23T00:00:00+0000
7PB2,Crystal structure of JDI TCR in complex with HLA-A*11:01 bound to KRAS G12D peptide (VVVGADGVGK),X-RAY DIFFRACTION,3.41,2022-07-20T00:00:00+0000,2024-10-23T00:00:00+0000
7PBC,Crystal structure of engineered TCR (796) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide,X-RAY DIFFRACTION,2.04,2022-08-03T00:00:00+0000,2024-10-09T00:00:00+0000
7PBE,Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope,X-RAY DIFFRACTION,3.0,2022-04-27T00:00:00+0000,2024-11-20T00:00:00+0000
7PDW,Crystal structure of parent TCR (728) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide,X-RAY DIFFRACTION,1.82,2022-08-03T00:00:00+0000,2024-10-23T00:00:00+0000
7Q98,MHC Class I A02 Allele presenting NLSALGIFST,X-RAY DIFFRACTION,2.5,2023-02-22T00:00:00+0000,2024-11-13T00:00:00+0000
7Q99,"MHC Class I A02 Allele presenting NLSALGIFST, in complex with Mel5 TCR",X-RAY DIFFRACTION,2.55,2023-02-22T00:00:00+0000,2024-11-20T00:00:00+0000
7Q9A,"MHC Class I A02 Allele presenting LLLGIGILVL, in complex with Mel5 TCR",X-RAY DIFFRACTION,2.1,2023-02-22T00:00:00+0000,2024-11-13T00:00:00+0000
7Q9B,"MHC Class I A02 Allele presenting EAAGIGILTV, in complex with Mel8 TCR",X-RAY DIFFRACTION,3.24,2023-02-22T00:00:00+0000,2024-11-20T00:00:00+0000
7QPJ,Crystal structure of engineered TCR (756) complexed to HLA-A*02:01 presenting MAGE-A10 9-mer peptide,X-RAY DIFFRACTION,1.54,2022-08-03T00:00:00+0000,2024-11-06T00:00:00+0000
7R7V,Crystal structure of HLA-B*5301 complex with an HIV-1 Gag-derived epitope QW9,X-RAY DIFFRACTION,1.6,2022-06-29T00:00:00+0000,2024-10-30T00:00:00+0000
7R7W,Crystal structure of HLA-B*5301 complex with an HIV-1 Gag-derived epitope QW9 S3T variant,X-RAY DIFFRACTION,1.17,2022-06-29T00:00:00+0000,2024-11-13T00:00:00+0000
7R7X,Crystal structure of HLA-B*5701 complex with an HIV-1 Gag-derived epitope QW9,X-RAY DIFFRACTION,2.099,2022-06-29T00:00:00+0000,2024-11-13T00:00:00+0000
7R7Y,Crystal structure of HLA-B*5701 complex with an HIV-1 Gag-derived epitope QW9 S3T variant,X-RAY DIFFRACTION,1.601,2022-06-29T00:00:00+0000,2024-11-06T00:00:00+0000
7R80,Crystal structure of C3 TCR complex with QW9-bound HLA-B*5301,X-RAY DIFFRACTION,2.9,2022-06-29T00:00:00+0000,2024-10-23T00:00:00+0000
7RE7,TCR mimic antibody (Fab fragment) in complex with AFP/HLA-A*02,X-RAY DIFFRACTION,2.547,2022-07-27T00:00:00+0000,2024-10-23T00:00:00+0000
7SA2,SARS-CoV-2 spike-derived peptide S1060-1068 (VVFLHVTYV) presented by HLA-A*02:01,X-RAY DIFFRACTION,1.85,2022-09-21T00:00:00+0000,2024-10-23T00:00:00+0000
7SIF,"Crystal Structure of HLA B*3505 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I",X-RAY DIFFRACTION,1.73,2022-11-23T00:00:00+0000,2024-11-06T00:00:00+0000
7SIG,"Crystal Structure of HLA B*3501 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I",X-RAY DIFFRACTION,1.741,2022-11-23T00:00:00+0000,2024-10-23T00:00:00+0000
7SIH,"Crystal Structure of HLA B*3503 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I",X-RAY DIFFRACTION,1.9,2022-11-23T00:00:00+0000,2024-10-30T00:00:00+0000
7SU9,KRAS-G12D specific TCR9a in complex with C*05-GADGVGKSL,X-RAY DIFFRACTION,1.99,2022-06-08T00:00:00+0000,2024-10-23T00:00:00+0000
7T0L,HLA-B*27:05 in complex with the pan-HLA-Ia monoclonal antibody W6/32,X-RAY DIFFRACTION,3.0,2022-12-07T00:00:00+0000,2024-11-13T00:00:00+0000
7T5M,Structure of HLA-A*02:01-FLPTPEELGLLGPPRPQVLA complex,X-RAY DIFFRACTION,1.67,2022-12-14T00:00:00+0000,2024-10-23T00:00:00+0000
7WKJ,"A COVID-19 T-cell response detection method based on a newly identified human CD8+ T cell epitope from SARS-CoV-2-Hubei Province, 2021.",X-RAY DIFFRACTION,1.5,2022-03-02T00:00:00+0000,2024-10-23T00:00:00+0000
7WT3,Crystal structure of HLA-A*2402 complexed with 4-mer lipopeptide,X-RAY DIFFRACTION,1.88765498464,2022-06-22T00:00:00+0000,2023-11-29T00:00:00+0000
7WT4,Crystal structure of HLA-A*2402 complexed with 8-mer Influenza PB1 peptide,X-RAY DIFFRACTION,1.89459140677,2022-06-22T00:00:00+0000,2024-10-16T00:00:00+0000
7WT5,Crystal structure of HLA-A*2450 complexed with 8-mer model peptide,X-RAY DIFFRACTION,2.09507668635,2022-06-22T00:00:00+0000,2024-11-06T00:00:00+0000
7WZZ,Crystal structure of peptide KAGQVVTIW in complex with HLA-B5801,X-RAY DIFFRACTION,1.305,2023-05-03T00:00:00+0000,2024-11-20T00:00:00+0000
7X00,Crystal structure of peptide VSFIEFVGW in complex with HLA-B5801,X-RAY DIFFRACTION,1.45,2023-05-03T00:00:00+0000,2024-11-06T00:00:00+0000
7XF3,The structure of HLA-B*1501/BM58-66AF9,X-RAY DIFFRACTION,1.91,2023-02-08T00:00:00+0000,2024-11-06T00:00:00+0000
7YG3,Crystal structure of HLA-B*13:01,X-RAY DIFFRACTION,1.5,2023-07-26T00:00:00+0000,2024-10-09T00:00:00+0000
7ZUC,Human Major Histocompatibility Complex A2 allele presenting LLLGIGILV,X-RAY DIFFRACTION,1.89,2023-05-24T00:00:00+0000,2024-11-06T00:00:00+0000
8CX4,TCR-antigen complex AS8.4-YEIH-HLA*B27,X-RAY DIFFRACTION,2.2,2022-12-07T00:00:00+0000,2024-11-06T00:00:00+0000
8E13,Structures of HLA-B8E76C loaded with long peptides reveal novel features at the N-terminus of the groove,X-RAY DIFFRACTION,1.37,2023-07-26T00:00:00+0000,2024-11-13T00:00:00+0000
8E8I,Structures of HLA-B8E76C loaded with long peptides reveal novel features at the N-terminus of the groove,X-RAY DIFFRACTION,1.49,2023-07-26T00:00:00+0000,2024-11-20T00:00:00+0000
8EC5,Structures of HLA-B8E76C loaded with long peptides reveal novel features at the N-terminus of the groove,X-RAY DIFFRACTION,1.22,2023-07-26T00:00:00+0000,2024-10-23T00:00:00+0000
8EK5,Engineered scFv 10LH bound to PHOX2B/HLA-A24:02,X-RAY DIFFRACTION,2.11,2023-12-06T00:00:00+0000,2024-10-23T00:00:00+0000
8EMF,Crystal structure of a HLA-B*35:01-NP6 epitope from 1977 H1N1 influenza strain,X-RAY DIFFRACTION,1.80482421415,2024-03-27T00:00:00+0000,2024-10-30T00:00:00+0000
8EMG,Crystal structure of a HLA-B*35:01-NP7 epitope from 2002 H2N1 influenza strain,X-RAY DIFFRACTION,1.83001273614,2024-03-27T00:00:00+0000,2024-10-30T00:00:00+0000
8EMI,Crystal structure of a HLA-B*35:01-NP8 epitope from 2005 H1N1 influenza strain,X-RAY DIFFRACTION,1.57301511861,2024-03-27T00:00:00+0000,2024-11-13T00:00:00+0000
8EMJ,Crystal structure of HLA-B*35:01-NP9 epitope from 2006 H1N1 influenza strain,X-RAY DIFFRACTION,1.75002880736,2024-03-27T00:00:00+0000,2024-11-06T00:00:00+0000
8EMK,Crystal structure of HLA-B*35:01-NP3 epitope from 1957 H2N2 influenza strain,X-RAY DIFFRACTION,1.66523002948,2024-03-27T00:00:00+0000,2024-10-16T00:00:00+0000
8EN8,Cross-reactive 3180 TCR recognition of HLA-B*35:01-NP4 epitope from 1972 influenza strain,X-RAY DIFFRACTION,2.70001191123,2024-03-27T00:00:00+0000,2024-11-20T00:00:00+0000
8ENH,Cross-reactive 3180 TCR recognition of HLA-B*35:01-NP7 epitope from 2002 H3N2 influenza strain,X-RAY DIFFRACTION,2.50003195312,2024-03-27T00:00:00+0000,2024-11-13T00:00:00+0000
8EO8,Cross-reactive 3180 TCR recognition of HLA-B*35:01-NP8 epitope from 2005 H1N1 influenza strain,X-RAY DIFFRACTION,2.30000092477,2024-03-27T00:00:00+0000,2024-10-23T00:00:00+0000
8ES8,CryoEM structure of PN45545 TCR-CD3 in complex with HLA-A2 MAGEA4 (230-239),ELECTRON MICROSCOPY,2.65,2023-05-03T00:00:00+0000,2024-11-20T00:00:00+0000
8ES9,CryoEM structure of PN45428 TCR-CD3 in complex with HLA-A2 MAGEA4,ELECTRON MICROSCOPY,3.25,2023-05-03T00:00:00+0000,2024-10-30T00:00:00+0000
8FJA,CryoEM structure of HLA-A2 MAGEA4 (230-239) in complex with REGN6972 Fab,ELECTRON MICROSCOPY,3.0,2023-12-20T00:00:00+0000,2025-05-21T00:00:00+0000
8FJB,CryoEM structure of HLA-A2 MAGEA4 (286-294) in complex with H2aM31345N Fab,ELECTRON MICROSCOPY,3.06,2023-12-20T00:00:00+0000,2024-11-13T00:00:00+0000
8GOM,SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-HLA-A2,X-RAY DIFFRACTION,2.783,2023-03-01T00:00:00+0000,2024-10-30T00:00:00+0000
8GON,SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-T1006I-HLA-A2,X-RAY DIFFRACTION,2.601,2023-03-01T00:00:00+0000,2024-11-13T00:00:00+0000
8GVB,The complex between public TCR TD08 and HLA-A24 bound to HIV-1 Nef138-8 peptide,X-RAY DIFFRACTION,3.2,2022-10-19T00:00:00+0000,2024-10-30T00:00:00+0000
8GVG,The complex between public TCR TD08 and HLA-A24 bound to HIV-1 Nef138-8 (2F) peptide,X-RAY DIFFRACTION,3.37,2022-10-19T00:00:00+0000,2024-11-20T00:00:00+0000
8GVI,The complex between H25-11 TCR and HLA-A24 bound to HIV-1 Nef138-8 peptide,X-RAY DIFFRACTION,3.3,2022-10-19T00:00:00+0000,2024-10-23T00:00:00+0000
8HN4,Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope QYIKWPWYI,X-RAY DIFFRACTION,2.853,2023-12-27T00:00:00+0000,2024-10-30T00:00:00+0000
8ISN,HLA-A24 in complex with modified 9mer WT1 peptide,X-RAY DIFFRACTION,2.48,2023-09-13T00:00:00+0000,2024-10-23T00:00:00+0000
8RJ5,P1-15 T-cell Receptor bound to HLA A*2402-NF9 pMHC complex,X-RAY DIFFRACTION,3.02,2025-01-01T00:00:00+0000,2025-01-01T00:00:00+0000
8RJH,HLA A*2402-NF9_6F pMHC complex,X-RAY DIFFRACTION,2.6,2025-01-01T00:00:00+0000,2025-01-01T00:00:00+0000
8RJI,HLA A*2402-NF9_5R pMHC complex,X-RAY DIFFRACTION,2.3,2025-01-01T00:00:00+0000,2025-01-01T00:00:00+0000
8RNG,"Crystal structure of HLA B*18:01 in complex with TEVETYVL, an 8-mer epitope from Influenza A",X-RAY DIFFRACTION,1.45,2024-05-08T00:00:00+0000,2025-05-21T00:00:00+0000
8RNH,"Crystal structure of HLA B*18:01 in complex with EEIEITTHF, an 9-mer epitope from Influenza A",X-RAY DIFFRACTION,1.6,2024-05-08T00:00:00+0000,2024-11-20T00:00:00+0000
8ROO,"Crystal structure of HLA B*18:01 in complex with YERMCNIL, an 8-mer epitope from Influenza A",X-RAY DIFFRACTION,1.4,2024-05-08T00:00:00+0000,2024-11-06T00:00:00+0000
8ROP,"Crystal structure of HLA B*18:01 in complex with QEIRTFSF, an 8-mer epitope from Influenza A",X-RAY DIFFRACTION,1.15,2024-05-08T00:00:00+0000,2024-11-06T00:00:00+0000
8RYN,Structure of S2 TCR in complex with HLA-A*11:01 bound to ELFSYLIEK peptide,X-RAY DIFFRACTION,1.97,2024-09-04T00:00:00+0000,2025-02-12T00:00:00+0000
8RYQ,Structure of S8-9F3 TCR in complex with HLA-A*11:01 bound to ELFSYLIEK peptide,X-RAY DIFFRACTION,2.49,2024-09-04T00:00:00+0000,2025-02-12T00:00:00+0000
8SBK,"Structure of HLA-A*24:02 in complex with peptide, LYLPVRVLI (ATG2A).",X-RAY DIFFRACTION,1.8,2023-12-06T00:00:00+0000,2024-10-16T00:00:00+0000
8SBL,"Structure of HLA-A*24:02 in complex with peptide, LYLPVRVLI",X-RAY DIFFRACTION,3.0,2023-12-06T00:00:00+0000,2024-10-16T00:00:00+0000
8T6M,Human leukocyte antigen bound by two alloreactive antibody Fabs,ELECTRON MICROSCOPY,3.14,2024-12-25T00:00:00+0000,2024-12-25T00:00:00+0000
8V4Z,Crystal structure of a HLA-B*35:01-NP7 with D1 TCR,X-RAY DIFFRACTION,2.40000208775,2024-12-18T00:00:00+0000,2025-02-26T00:00:00+0000
8WUL,Crystal structure of affinity enhanced TCR in complex with HLA-A*11:01 bound to KRAS-G12V peptide (VVGAVGVGK),X-RAY DIFFRACTION,2.36,2024-05-01T00:00:00+0000,2024-10-16T00:00:00+0000
8YIV,N17.1.2 recognition of NRAS neoantigens,X-RAY DIFFRACTION,2.101,2024-12-04T00:00:00+0000,2024-12-04T00:00:00+0000
8YZR,The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYNYLYRLL(EG.5.1),X-RAY DIFFRACTION,1.8,2025-01-29T00:00:00+0000,2025-05-28T00:00:00+0000
8YZW,The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYDYWYRLF(BA.2.86),X-RAY DIFFRACTION,2.36,2025-01-29T00:00:00+0000,2025-05-28T00:00:00+0000
8YZZ,The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYNYLYRLF(Prototype),X-RAY DIFFRACTION,1.88,2025-01-29T00:00:00+0000,2025-05-28T00:00:00+0000
8Z06,The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYDYWYRSF(JN.1),X-RAY DIFFRACTION,2.39,2025-01-29T00:00:00+0000,2025-05-28T00:00:00+0000
8Z07,The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYNYRYRLF(Delta/BA.5.2),X-RAY DIFFRACTION,2.7,2025-01-29T00:00:00+0000,2025-05-28T00:00:00+0000
8Z08,The structure of HLA-A*2402 complex with peptide from SARS-CoV-2 S448-456 NYNYQYRLF(BA.2.12.1),X-RAY DIFFRACTION,2.01,2025-01-29T00:00:00+0000,2025-05-28T00:00:00+0000
8ZV9,Complex structure of HLA2402 with recognizing SARS-CoV-2 Y453F epitope NYNYLFRLF,X-RAY DIFFRACTION,2.6,2024-08-21T00:00:00+0000,2024-11-13T00:00:00+0000
9BL5,KIR3DL1*001 in complex with HLA-A*24:02 presenting the TW9 peptide,X-RAY DIFFRACTION,2.0,2024-11-13T00:00:00+0000,2024-12-11T00:00:00+0000
9BL6,KIR3DL1*114 in complex with HLA-A*24:02 presenting the TW9 peptide,X-RAY DIFFRACTION,2.4,2024-11-13T00:00:00+0000,2024-12-11T00:00:00+0000
9BL9,KIR3DL1*114 in complex with HLA-A*24:02 presenting the NEF peptide,X-RAY DIFFRACTION,2.6,2024-11-13T00:00:00+0000,2024-12-11T00:00:00+0000
9BLA,KIR3DL1*086 in complex with HLA-A*24:02 presenting the NEF peptide,X-RAY DIFFRACTION,3.0,2024-11-13T00:00:00+0000,2024-12-11T00:00:00+0000
9C96,Cryo-EM structure of TAP binding protein related (TAPBPR) in complex with HLA-A*02:01 bound to a suboptimal peptide.,ELECTRON MICROSCOPY,3.0,2025-01-22T00:00:00+0000,2025-01-29T00:00:00+0000
9GV6,Structure of TCR in complex with peptide-HLA,X-RAY DIFFRACTION,2.77,2025-04-23T00:00:00+0000,2025-04-30T00:00:00+0000
9GV7,Structure of reverse docking TCR in complex with peptide-HLA,X-RAY DIFFRACTION,1.86,2025-04-23T00:00:00+0000,2025-04-30T00:00:00+0000
9L47,Crystal structure of HLA-C*12:03-MY9,X-RAY DIFFRACTION,2.8,2025-03-19T00:00:00+0000,2025-03-19T00:00:00+0000
9L48,Crystal structure of HLA-C*12:02-RV9,X-RAY DIFFRACTION,1.9,2025-03-19T00:00:00+0000,2025-03-19T00:00:00+0000
9L49,Crystal structure of HLA-C*12:03-RV9,X-RAY DIFFRACTION,3.0,2025-03-19T00:00:00+0000,2025-03-19T00:00:00+0000
9L4A,Crystal structure of HLA-C*12:02-MY9,X-RAY DIFFRACTION,1.9,2025-03-19T00:00:00+0000,2025-03-19T00:00:00+0000
